誉衡药业

- 002437

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
誉衡药业(002437) 利润表
单位:万元
报表日期2023-09-302023-06-302023-03-312022-12-312022-09-30
一、营业总收入205,200.85143,266.3268,116.90310,794.52241,505.68
营业收入205,200.85143,266.3268,116.90310,794.52241,505.68
二、营业总成本193,703.67133,998.8763,637.40304,595.32230,559.02
营业成本43,869.9430,068.0014,684.4071,921.4556,088.56
营业税金及附加2,825.941,982.67869.504,151.803,053.98
销售费用126,734.6288,243.4541,733.28192,503.31146,750.14
管理费用11,573.217,786.683,402.4321,280.9214,132.46
财务费用2,666.522,238.931,548.064,674.803,180.31
研发费用6,033.443,679.151,399.7310,063.047,353.55
资产减值损失----------
公允价值变动收益-1,658.67-1,367.05-182.54-2,475.23-2,765.90
投资收益9,318.71-4,419.29-2,077.48-24,481.49-3,834.82
其中:对联营企业和合营企业的投资收益9,196.14-4,539.72-2,097.35-24,642.58-3,984.40
汇兑收益----------
三、营业利润26,040.975,137.143,221.62-27,008.546,855.18
加:营业外收入60.3037.753.48173.0924.31
减:营业外支出81.4836.8123.76132.4199.63
其中:非流动资产处置损失----------
四、利润总额26,019.795,138.083,201.35-26,967.866,779.85
减:所得税费用2,913.681,909.781,014.301,983.923,049.31
五、净利润23,106.113,228.302,187.04-28,951.773,730.55
归属于母公司所有者的净利润22,362.352,824.902,005.86-29,132.883,010.48
少数股东损益743.75403.40181.18181.11720.06
六、每股收益
基本每股收益(元/股)0.10170.01290.0091-0.13250.0137
稀释每股收益(元/股)0.10170.01290.0091-0.13250.0137
七、其他综合收益136.14164.02-71.40502.17576.43
八、综合收益总额23,242.253,392.332,115.64-28,449.614,306.98
归属于母公司所有者的综合收益总额22,498.502,988.931,934.46-28,630.723,586.91
归属于少数股东的综合收益总额743.75403.40181.18181.11720.06
下载全部历史数据到excel中 返回页顶